0001288469-19-000188.txt : 20191122 0001288469-19-000188.hdr.sgml : 20191122 20191122160946 ACCESSION NUMBER: 0001288469-19-000188 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191120 FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LITCHFIELD STEVEN G CENTRAL INDEX KEY: 0001286030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34666 FILM NUMBER: 191241641 MAIL ADDRESS: STREET 1: C/O MAXLINEAR, INC. STREET 2: 5966 LA PLACE COURT, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAXLINEAR INC CENTRAL INDEX KEY: 0001288469 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 141896129 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-692-0711 MAIL ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 wf-form4_157445697081449.xml FORM 4 X0306 4 2019-11-20 0 0001288469 MAXLINEAR INC MXL 0001286030 LITCHFIELD STEVEN G C/O MAXLINEAR, INC. 5966 LA PLACE COURT, SUITE 100 CARLSBAD CA 92008 0 1 0 0 See remarks Common Stock 2019-11-20 4 M 0 1123 0 A 59950 D Common Stock 2019-11-20 4 F 0 1123 19.99 D 58827 D Restricted Stock Units 2019-11-20 4 M 0 1123 0 D Common Stock 1123.0 35750 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock. Includes 1,012 shares of Common Stock acquired under the Company's 2010 Employee Stock Purchase Plan on November 15, 2019. Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the 52,000 RSUs subject to the award shall vest on August 20, 2019, and an additional one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each November 20, February 20, May 20, and August 20 thereafter, such that the award will be fully vested on August 20, 2022. Chief Financial Officer and Chief Corporate Strategy Officer /s/ Connie Kwong, as Attorney-in-Fact 2019-11-22